⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8769739 | 0.76 | — | — | |
| SCHEMBL16287908 | 0.73 | — | — | |
| SCHEMBL16288820 | 0.69 | — | — | |
| SCHEMBL16287996 | 0.67 | — | — | |
| SCHEMBL972049 | 0.66 | — | — | |
| SCHEMBL16288051 | 0.66 | — | — | |
| SCHEMBL3268270 | 0.65 | — | — | |
| SCHEMBL562805 | 0.64 | — | — | |
| SCHEMBL12678052 | 0.64 | — | — | |
| SCHEMBL5985939 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11964938-B2 | 3-phenyl-4-hexynoic acid derivatives as GPR40 agonists | CELON PHARMA S.A. (PL) | 2024-04-23 | — | — | US | disclosed |
| EP-3737470-B9 | 3-PHENYL-4-HEXYNOIC ACID DERIVATIVES AS GPR40 AGONISTS | Celon Pharma Sa (PL) | 2024-03-13 | — | — | EP | disclosed |
| EP-3927703-B1 | ANTIBACTERIALS BASED ON MONOCYCLIC FRAGMENTS COUPLED TO AMINOPIPERIDINE NAPHTHYRIDINE SCAFFOLD | UNIV LJUBLJANI (SI) | 2023-04-05 | — | — | EP | disclosed |
| EP-3737470-B1 | 3-PHENYL-4-HEXYNOIC ACID DERIVATIVES AS GPR40 AGONISTS | Celon Pharma Sa (PL) | 2022-12-14 | — | — | EP | disclosed |
| US-20220023275-A1 | Aqueous Based Pharmaceutical Formulations of 1,2-Dihydropyridine Compounds | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2022-01-27 | — | — | US | disclosed |
| EP-3927703-A1 | ANTIBACTERIALS BASED ON MONOCYCLIC FRAGMENTS COUPLED TO AMINOPIPERIDINE NAPHTHYRIDINE SCAFFOLD | Univerza V Ljubljani (SI) | 2021-12-29 | — | — | EP | disclosed |
| EP-3893844-A1 | AQUEOUS BASED PHARMACEUTICAL FORMULATIONS OF 1,2-DIHYDROPYRIDINE COMPOUNDS | Eisai R&D Management Co., Ltd. (JP) | 2021-10-20 | — | — | EP | disclosed |
| CN-113226286-A | Water-based pharmaceutical formulations of 1, 2-dihydropyridine compounds | 卫材R&D管理有限公司 | 2021-08-06 | — | — | CN | disclosed |
| US-20200399198-A1 | 3-PHENYL-4-HEXYNOIC ACID DERIVATIVES AS GPR40 AGONISTS | CELON PHARMA S.A. (PL) | 2020-12-24 | — | — | US | disclosed |
| EP-3737470-A1 | 3-PHENYL-4-HEXYNOIC ACID DERIVATIVES AS GPR40 AGONISTS | CELON PHARMA S.A. (PL) | 2020-11-18 | — | — | EP | disclosed |
| US-20030078277-A1 | Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2003-04-24 | — | — | US | disclosed |
| EP-1300396-A1 | 1,2-DIHYDROPYRIDINE COMPOUNDS, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF | Eisai Co., Ltd. (JP) | 2003-04-09 | — | — | EP | disclosed |
| EP-1292573-A2 | SUBSTITUTED THIOACETAMIDES | CEPHALON, INC. (US) | 2003-03-19 | — | — | EP | disclosed |
| US-6492396-B2 | Substituted thioacetamides | CEPHALON, INC. | 2002-12-10 | — | — | US | disclosed |
| US-20020183334-A1 | Substituted thioacetamides | CEPHALON, INC. | 2002-12-05 | — | — | US | disclosed |
| EP-1254904-A1 | NOVEL PIPERIDINE COMPOUNDS AND DRUGS CONTAINING THE SAME | Eisai Co., Ltd. (JP) | 2002-11-06 | — | — | EP | disclosed |
| EP-1254895-A1 | NITROGENOUS CYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Eisai Co., Ltd. (JP) | 2002-11-06 | — | — | EP | disclosed |
| EP-1238979-A1 | FUSED HETEROTRICYCLIC COMPOUNDS, PROCESS FOR PREPARING THE COMPOUNDS AND DRUGS CONTAINING THE SAME | Eisai Co., Ltd. (JP) | 2002-09-11 | — | — | EP | disclosed |
| US-20020045629-A1 | Substituted thioacetamides | CEPHALON, INC. | 2002-04-18 | — | — | US | disclosed |
| WO-2001087830-A2 | SUBSTITUTED THIOACETAMIDES | CEPHALON, INC. (US) | 2001-11-22 | — | — | WO | disclosed |